Jushi Holdings (JUSHF) Short-term Investments (2023 - 2024)
Jushi Holdings' (JUSHF) quarterly Short-term Investments came in at $3.1 million in Q1 2024, little changed on a QoQ basis from $3.1 million in Q4 2023.
Jushi Holdings (JUSHF) Short-term Investments (2023 - 2024) Analysis & Trends
Jushi Holdings (JUSHF) has 2 years of Short-term Investments data on file, last reported at $3.1 million in Q1 2024.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $3.1 million in Q1 2024; TTM through Mar 2024 was $3.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $3.1 million, changed N/A from the prior year.
- Short-term Investments for Q1 2024 stood at $3.1 million, roughly flat from $3.1 million in the prior quarter.
- Over the last five years, Short-term Investments for JUSHF reached as high as $3.3 million in Q3 2023 and fell as low as $3.1 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.13 Mn |